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Abstract
We report that visual arrestin can regulate retinal release and late photoproduct formation in rhodopsin. Our experiments, which
employ a Xuorescently labeled arrestin and rhodopsin solubilized in detergent/phospholipid micelles, indicate that arrestin can trap a
population of retinal in the binding pocket with an absorbance characteristic of Meta II with the retinal SchiV-base intact. Furthermore,
arrestin can convert Metarhodopsin III (formed either by thermal decay or blue-light irradiation) to a Meta II-like absorbing species.
Together, our results suggest arrestin may be able to play a more complex role in the rod cell besides simply quenching transducin activ-
ity. This possibility may help explain why arrestin deWciency leads to problems like stationary night blindness (Oguchi disease) and retinal
degeneration.
© 2006 Elsevier Ltd. All rights reserved.
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For over twenty years arrestin has been known as the
ultimate quencher of light-induced rhodopsin signaling
(Kühn, Hall, & Wilden, 1984; Wilden, Hall, & Kühn, 1986).
It does so by binding to the phosphorylated form of light-
activated rhodopsin, thus blocking further interaction of
rhodopsin with transducin (Burns & Baylor, 2001; Hurley,
Spencer, & Niemi, 1998; Ridge, Abdulaev, Sousa, & Pal-
czewski, 2003). In this paper, we present evidence obtained
in vitro that suggests interaction of arrestin with rhodopsin
can also regulate the photochemistry of rhodopsin, which
could have important functions in vivo.
The molecular details of the rhodopsin photo-cycle have
been well studied. BrieXy, activation of rhodopsin
(max » 500 nm) begins with light-induced isomerization of
the covalently attached chromophore 11-cis retinal to all-
trans retinal (Hubbell, Altenbach, Hubbell, & Khorana,
2003; Wald, 1968). This event leads to the formation of two
photoproducts, Meta I (max » 480 nm) and Meta II
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doi:10.1016/j.visres.2006.08.031(max » 380 nm), which are in equilibrium (Parkes, Gibson,
& Liebman, 1999; Schertler, 2005). Meta II is the active sig-
naling form of the receptor that couples to transducin
(Burns & Baylor, 2001; Hamm, 2001).
Light-activated rhodopsin can decay by diVerent but
parallel pathways. The retinal SchiV-base of Meta II is sen-
sitive to cleavage, and thus Meta II eventually decays to
opsin and free retinal (Bownds & Wald, 1965; Farrens &
Khorana, 1995). Alternatively, retinal SchiV-base isomeri-
zation in Meta I forms the long-lived photoproduct Meta
III (max » 470 nm) (Vogel et al., 2003; Vogel, Siebert,
Zhang, Fan, & Sheves, 2004b). Up to half of the rhodopsin
in the human retina may be converted to Meta III in bright-
light conditions (Lewis, van Kuijk, Carruthers, & Kliger,
1997). Meta III may thus exist for retinal storage purposes
(Heck et al., 2003a), although it also retains some signaling
ability (Zimmermann, Ritter, Bartl, Hofmann, & Heck,
2004).
Other wavelengths of light can cause further photo-con-
versions of rhodopsin (Hubbard & Kropf, 1958). For exam-
ple, blue light (<420 nm) can convert Meta II into other
photoproducts, including Meta III (Ritter, Zimmermann,
Heck, Hofmann, & Bartl, 2004) and P500 (max » 500 nm)
(Arnis & Hofmann, 1995). P500 appears to be similar to
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ston & Williams, 1977), although it might actually bind an
all-trans retinal (Bartl, Ritter, & Hofmann, 2001).
In the current study, we address how arrestin can aVect
the formation and decay of these photoproducts. Under-
standing these processes is important for understanding the
visual photo-cycle, especially since arrestin is likely to
encounter these photoproducts in the light-exposed rod
cell. We are exploring these questions using new in vitro
approaches, which include a Xuorescently labeled arrestin
mutant, as well as a functional solubilized system in which
to monitor arrestin–rhodopsin interactions (Sommer,
Smith, & Farrens, 2005; Sommer, Smith, & Farrens, 2006).
Here, we summarize this recent work, which shows that arr-
estin can stabilize Meta II, both by inhibiting retinal release
and Meta III formation, and by interacting with Meta III
and converting it to a Meta II-like species. We also present
new data, which shows that irradiation of arrestin-bound
Meta II can result in a P500-like product that no longer
binds arrestin.
Finally, based on a review of the literature (see Section
4) as well as our results, we present a hypothesis that arres-
tin may have a biological role to limit retinal release in the
photo-bleached retina, which could help protect the cell
from long-term oxidative damage (Sparrow et al., 2003). In
addition, we speculate that arrestin may regulate the photo-
product Meta III, and this interaction may be necessary for
proper dark adaptation (Lamb & Pugh, 2004).
2. Materials and methods
2.1. Materials
Except where noted below, all reagents were obtained from Sigma (St.
Louis, MO). Frozen bovine retinas were obtained from Lawson and Law-
son, Inc. (Lincoln, NE), and 11-cis retinal was a generous gift from Rosalie
Crouch (Medical University of South Carolina and National Eye Insti-
tute). Monobromobimane was purchased from Molecular Probes
(Eugene, OR), and spectroscopic-grade buVers were from USB Corpora-
tion (Cleveland, OH). Acrylamide/bisacrylamine solution (37:5:1) was pur-
chased from Bio-Rad, and Concavalin A Sepharose was obtained from
Amersham (Piscataway, NJ). N-dodecyl--D-maltopyranoside (DM) was
from Anatrace (Maumee, OH), and asolectin was purchased from Fluka
(Buchs, Switzerland). Asolectin, an inexpensive mixture of soybean phos-
pholipids, is often used to reconstitute puriWed rhodopsin (Mansoor, Pal-
czewski, & Farrens, 2006; Niu, Kim, & Khorana, 2002). It consists of
roughly equal parts of phosphatidylcholine, phosphatidylethanolamine,
and phosphatidylinositol (product information as provided from manu-
facturer). To prepare asolectin/DM mixed micelles, a stock of 1% asolectin
and 1% DM was made by dispersing the powdered asolectin into solution
with a syringe and needle. The solution was clariWed by centrifugation
(100,000g, 20 min) before use.
2.2. PuriWcation of native rhodopsin and recombinant arrestin
Rod outer segment (ROS) membranes containing native rhodopsin,
and highly phosphorylated ROS, were prepared from bovine retinas.
Phosphorylated rhodopsin (Rho-P) was puriWed from ROS using ConA
and solubilized in DM as described previously (Sommer et al., 2005, 2006),
and puriWed samples had a 280/500 nm absorbance ratio of 1.6. Mutant
arrestin constructs W194F and I72C/W194F were created from the bovine
visual arrestin cDNA (a gift from V.V. Gurevich) cloned in the pET15bvector (Invitrogen). All constructs were veriWed by DNA sequencing, arr-
estin was expressed and puriWed from Escherichia coli BL21(DE3) cells,
and arrestin samples were subsequently labeled with monobromobimane
as described (Sommer et al., 2006). Recombinant arrestin I72C/W194F
labeled at »92% eYciency; recombinant arrestin W194F labeled at less
than 2% eYciency. No free label contamination was detected in the labeled
arrestin samples. The bimane-labeled arrestin mutant I72C/W194F is sub-
sequently referred to as I72B.
2.3. Fluorescence spectroscopy
All steady-state and time-resolved Xuorescence measurements were
made using a Photon Technologies steady-state spectrophotometer with a
single excitation source (DeltaRam) and two emission detectors (T for-
mat). Excitation slits were set <0.25 nm to avoid bleaching of rhodopsin,
and emission slits were set at 15 nm band pass. For emission scans, the
sample was excited at 380 nm, and emission was measured from 400 to
600 nm using 2 nm increments (0.25 s integration per point). For simulta-
neous monitoring of retinal and arrestin release, the sample was excited
for 1 s at 295 nm, followed by 1 s at 380 nm. Emission was detected at 330
and 456 nm, and the shutter was closed for 8 s between measurements. In
this way, retinal release was monitored as an increase in opsin tryptophan
Xuorescence (ex: 295 nm, em: 330 nm), and arrestin binding and release
were monitored as changes in bimane Xuorescence (ex: 380 nm, em:
456 nm). Samples were photoactivated using a 150-W Wber optic light
source (>495 nm). Background Xuorescence was subtracted from all data,
and steady-state scans were smoothed using the program Felix (Sommer
et al., 2005, 2006).
2.4. UV–visible absorbance spectroscopy
All UV–visible absorption spectra were recorded with a Shimadzu
UV-1601 spectrophotometer (bandwidth of 2 nm) (Sommer et al., 2006).
For the photodecay experiments, the absorbance of 1 M Rho-P (120 l)
was recorded in the dark after base-lining the spectrophotometer with the
appropriate buVer. The sample was photoactivated (>495 nm) for 20 s, and
spectra were subsequently recorded every 90 s for 120 min. For blue-light
experiments, the sample was illuminated by a Machine Vision Strobe light
source Wltered through a 400 § 20 nm band pass Wlter for 20 s. The pres-
ence of SchiV-base was ascertained by the addition of 5 l of 0.8 N H2SO4
to the sample.
2.5. NaBH4 reduction and V8 proteolysis of rhodopsin
The Xuorescent n-retinylidene opsin species (ex: 340 nm, em: 480 nm)
results from reduction of the SchiV-base in rhodopsin with NaBH4 (Bownds
& Wald, 1965; Farrens & Khorana, 1995). Samples of 3M Rho-P, with or
without 6M arrestin W194F, solubilized in 0.02% DM or 0.02% DM and
0.02% asolectin (20l) were photo-activated (>495 nm, 20 s, 20 °C), incu-
bated in the dark for 120 min, and then 5 l of 1% NaBH4 was added to each
sample. After 10 min, 15 l of 1 M sodium phosphate (pH 7.0) was added,
and each sample was split into two 20l aliquots. Five microliters of 4.8 M
V8 protease was added to half the samples, and proteolysis occurred for
30 min at 20 °C. To assess the amount of SchiV-base present in Meta II rho-
dopsin immediately after activation, 1% NaBH4 was added to Rho-P (0.02%
DM) in the dark, followed by photo-activation at 4 °C. Samples were sub-
jected to 15% Tris–tricine–SDS–PAGE, and gels were soaked in 30% metha-
nol before visualization. Bands were visualized using excitation from a short
wave UV source (Alpha-Innotech FluorChem 5500 gel-doc) and a CCD
camera (535 § 50 nm cut-oV Wlter; 10 min exposure). AlphaEase FC soft-
ware was used to quantify the Xuorescence of the bands.
2.6. Arrestin functional “pull-down” assay
Arrestin’s ability to bind Rho-P in native membranes (ROS-P) was
performed as described previously with some modiWcations (Sommer
et al., 2005). BrieXy, a single sample of sonicated ROS-P (15 M) was
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dark (120 l, 20 mM Hepes, 150 mM NaCl, pH 7.4, 20 °C). 20 l aliquots
were removed and immediately placed on ice in the dark, after green light
illumination (>495 nm, 60 s), after subsequent blue-light illumination
(<420 nm, 60 s), after subsequent green light illumination (60 s), and after
the addition of 10 mM hydroxylamine. The sample was illuminated from
the top to prevent the plastic tube from Wltering the light. The samples
were then diluted 10-fold with ice-cold buVer, centrifuged at 100,000g for
10 min (4 °C), and the pellets were solubilized in loading buVer and sub-
jected to SDS–PAGE (10%). The gel was visualized as described above
using a gel-doc apparatus, and bands were quantiWed using the AlphaEase
FC software.
3. Results
3.1. Fluorescent arrestin binding to rhodopsin in mixed 
micelles
Arrestin binding and release from light-activated
phosphorylated rhodopsin (Rho*-P) in native ROS
membranes can be monitored with Xuorescently labeled
arrestin mutants (Sommer et al., 2005). SpeciWcally,
bimane-labeled arrestin I72C (I72B) exhibits a blue-shift
and increase in Xuorescence upon binding Rho*-P. The
blue-shift indicates the probe is relocated into a morehydrophobic domain (Mansoor, McHaourab, & Farrens,
1999). Thus, this Xuorescence change is most likely due to
a burying of the bimane probe in a protein-protein or a
protein-lipid interface. Fig. 1 illustrates the location of
the Xuorescent probe on arrestin and the likely binding
interfaces between rhodopsin and arrestin.
Using this approach, we recently made an unexpected
discovery. We found that although arrestin binding to
Rho¤-P is inhibited when Rho-P is puriWed and solubilized
in n-dodecyl--D-maltopyranoside (DM), arrestin binding
can be restored with the addition of exogenous phospholip-
ids in the form of asolectin (Fig. 2A) (Sommer et al., 2006).
Furthermore, we found that acidic phospholipids (phos-
phatidylserine, phosphatidylinositol, and phosphatidic
acid) speciWcally enable arrestin binding (Sommer et al.,
2006). The high phosphatidylinositol content (»30%) of
asolectin probably explains why it serves as a good
enhancer of arrestin binding to DM-puriWed Rho-P.
Importantly, the ability to monitor arrestin binding to
Rho-P solubilized in mixed DM/asolectin micelles enables a
soluble system in which to study the dynamics of the inter-
action of arrestin with the major photoproducts of rhodop-
sin and how this inXuences the release of the retinalFig. 1. Cartoon representation of the experimental system used in this study. Possible arrangement of dark-state rhodopsin (gray) and a hypothetical
dimer partner (light gray) (Liang et al., 2003) in a mixed detergent/phospholipid micelle. The intradiskal and cytoplasmic domains of detergent-solubilized
rhodopsin are presumed to be exposed to solvent based on the dimensions of the DM micelle (Dupuy et al., 1997) and the facts that detergent-solubilized
rhodopsin can be bound by both N- and C-terminal antibodies and ConA. Arrestin I72B (white) is a mutant labeled with the Xuorescent probe monobro-
mobimane at the approximate location shown (note—the Xuorescent probe structure is not to scale with the protein model). The Xuorescence of I72B
increases upon binding to rhodopsin, and this fact was used to assay the interaction of these two proteins. The possible dimerization of rhodopsin and/or
arrestin was not addressed in this study, and is merely illustrated here for speculative interest (see text for more details).
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described below.
3.2. Arrestin traps a population of retinal in mixed micelles
We measured retinal release from Rho*-P solubilized in
mixed DM/asolectin micelles by monitoring the increase in
native opsin tryptophan Xuorescence that occurs when
retinal is released from the binding pocket (Farrens &
Khorana, 1995) (Fig. 2B). The data show that retinal
was released from Rho*-P in mixed micelles with a
t1/2 D 12.3 § 0.8 min, which is »1.6 times slower than in
native ROS membranes (Sommer et al., 2006). The addition
of hydroxylamine, a compound that cleaves the SchiV-base,
resulted in a small (»5%) increase in Xuorescence.
Strikingly, in the presence of a twofold excess of arrestin,
the tryptophan Xuorescence of Rho*-P plateaued at »half
that seen in the absence of arrestin, implying that arrestin
traps »half of the retinal population in the binding pocket
(Heck et al., 2003a). The addition of hydroxylamine caused
the Xuorescence to increase to the same level as seen in the
absence of arrestin. Interestingly, arrestin appeared to only
aVect the plateau of tryptophan Xuorescence and not the rate
at which the Xuorescence increased (t1/2D  13.2§0.7 min).
The Xuorescent arrestin I72B was used to monitor arres-
tin binding and release during the same experiment
described above (Fig. 2C). Arrestin binding to Rho*-P in
mixed micelles resulted in a »50% increase in bimane Xuo-
rescence. The rate of arrestin release was signiWcantly
slower (t1/2 » 25 min) compared to retinal release, and the
bimane Xuorescence plateaued at »70% of the starting state
intensity.2 Hydroxylamine returned the Xuorescence to the
starting-state level.
Note that, at this time, we are not able to correlate the
relative Xuorescence change of I72B to the concentration of
Rho*-P-bound arrestin, so we cannot quantify the ratio of
bound arrestin to trapped retinal. Thus, we can only con-
clude that while some arrestin remained bound in the com-
plex, » half of the retinal population was trapped.
3.3. Arrestin traps retinal as a SchiV-base adduct
We determined that the trapped retinal observed in
Fig. 2B represents a SchiV-base linked form, by reducing the
retinal SchiV-base with NaBH4, which results in a Xuorescent
1 An earlier study also looked at arrestin–rhodopsin interactions using
detergent-solubilized rhodopsin (Imamoto, Tamura, Kamikubo, & Kat-
aoka, 2003). However, as far as we are aware, our study is the Wrst to ex-
amine the eVect of arrestin on retinal release and photoproduct formation
using detergent-solubilized rhodopsin.
2 The plateau reported here is higher than in our previously published
data (Sommer et al., 2006), even though both experiments used DM/
asolectin mixed micelles. We do not know the cause of this variation,
but it may be due to the diVerence in background Xuorescence due to
the heterogenous nature of this phospholipid source. However, the reti-
nal release as ascertained by opsin tryptophan Xuorescence consistently
plateaus at 50%.n-retinylidene species (Bownds & Wald, 1965; Farrens &
Khorana, 1995). Subsequent SDS–PAGE enabled the sepa-
ration the n-retinylidene opsin from possible retinal–
phospholipid adducts (Sommer et al., 2006). We also digested
the reduced opsin with V8 protease to reveal the relative
Fig. 2. Arrestin can trap »half of the retinal population in opsin. (A)
Fluorescence of arrestin I72B (1 M) in the presence of a twofold excess of
puriWed Rho-P in DM-micelles (left panel) or DM/asolectin mixed
micelles (right panel). Smoothed spectra show before (solid trace) and
after (dashed trace) light-activation (ex D 380 nm, 20 °C). Data taken
from: (Sommer et al., 2006). (B) Retinal release from Rho-P in mixed
micelles measured as an increase in opsin tryptophan Xuorescence
(ex D 295 nm, em D 330 nm). Photoactivation occurred at t D 0 min, and
10 mM hydroxylamine was added at t D 120 min. Samples contained 1 M
Rho-P (0.02% DM and 0.02% asolectin) with or without a twofold excess
of arrestin I72B (20 mM Hepes, 150 mM NaCl, pH 7.4, 20 °C). (C) Arres-
tin binding and release measured during the same experiment as described
in (B) (ex D 380 nm, em D 456 nm). In parts (A–C) the data are plotted to
show the relative increase in Xuorescence, a value independent of instru-
mentation.
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cleaves opsin in the third cytoplasmic loop, resulting in two
fragments. The larger fragment F1 (»27 kDa) contains trans-
membrane helices 1–5, and the smaller fragment F2
(»15kDa) consists of transmembrane helices 6 and 7 (Far-
rens, Altenbach, Yang, Hubbell, & Khorana, 1996). Frag-
ment F2 also contains Lys296, to which retinal is attached in
dark-state and Meta II rhodopsin (Bownds, 1967).
When Rho-P in DM-micelles was reduced immediately
after photo-activation (Meta II), retinal is clearly attached
to F2 (Fig. 3B, lane 6). Two hours after photo-activation,
»25% of the original retinal population was attached to
opsin (Fig. 3A, lane 7). The V8 proteolysis assay revealed
some of this retinal is attached to both F1 and F2 of Rho-P
(Fig. 3B, lane 7). This residual retinal may represent Meta
III as well as retinal which attached to peripheral lysines on
Rho*-P after release from the binding pocket (Fishkin,
Jang, Itagaki, Sparrow, & Nakanishi, 2003). Note that the
Xuorescence of the V8 protease implies that some retinal
may attach to this enzyme as well. In the presence of arres-
tin (Fig. 3B, lane 8), the amount of retinal attached to opsin
in DM micelles was not signiWcantly changed.In DM/asolectin mixed micelles, only »10% of retinal
remained attached to opsin after photodecay (Fig. 3A, lane
9). Why is this value lower than in DM alone? A likely
explanation is that the phosphatidylethanolamine in aso-
lectin competes with lysine residues for retinal (Plack &
Pritchard, 1969; Sparrow et al., 2003), and this conclusion is
supported by the presence of a low molecular-weight Xuo-
rescent species (Fig. 3B, lanes 9 and 10). SigniWcantly, arres-
tin caused »60% of the retinal to remain attached to opsin,
and most of this retinal (»80%) was attached to F2
(Fig. 3B, lane 10). Besides illustrating the phospholipid-
dependence of retinal trapping by arrestin, these results
conWrm that arrestin acts to trap » half the retinal in opsin,
as suggested from the plateau in rhodopsin tryptophan
Xuorescence (Fig. 2B). In addition, it appears that arrestin
traps retinal on F2 of rhodopsin, possibly at Lys296.
3.4. Arrestin blocks Meta III formation and traps spectral 
Meta II
The photo-intermediates of Rho-P in DM/asolectin
micelles were assayed using UV–visible absorptionFig. 3. Arrestin traps retinal as a SchiV-base adduct on F2 of Rho*-P. (A) Reducing the retinal SchiV-base with NaBH4 produces a Xuorescent Rho*-P that
indicates the amount of retinal covalently attached to opsin. BrieXy, Rho-P solubilized in 0.02% DM or 0.02% DM and 0.02% asolectin, without or with a
twofold excess of arrestin, was photoactivated, allowed to decay at 20 °C in the dark, reduced after 120 min, and then subjected to SDS–PAGE. The total
amount of SchiV-base linked retinal was assessed by the reduction of Meta II Rho immediately after bleach (lanes 1 and 6). (B) The same samples as
described in (A) were subjected to V8 proteolysis. Molecular weight markers (kDa) are indicated on the left. In both (A) and (B), the Coomassie-stain (left,
lanes 1–5) and Xuorescence (right, lanes 6–10) of each gel is shown, and arrows on the right identify the bands: arrestin (Arr), rhodopsin (Rho), Rho frag-
ments resulting from V8 proteolysis (F1 and F2), the V8 protease (V8), and asolectin phospholipids (PL). (C) Plot of the average quantiWed Xuorescence
from four independent experiments as shown in (A). The Xuorescence is expressed as a percent of the total “Meta II” Xuorescence, and the error bars rep-
resent the standard error.
M.E. Sommer, D.L. Farrens / Vision Research 46 (2006) 4532–4546 4537spectroscopy (Fig. 4A). Dark-state Rho-P exhibited a
characteristic absorption maximum at 500 nm that
shifted to 380 nm after photo-activation. Over time, there
was a loss of absorbance at 380 nm and an increase in
absorbance between 450 and 480 nm. This event can be
explained as the conversion of Meta II (380 nm) to Meta
III (470 nm) and the release of retinal from the binding
pocket to form adducts with phospholipid head-groups
(440–450 nm).
However, when an excess of arrestin was present, the
photodecay absorption spectra of Rho-P were dramati-
cally diVerent (Fig. 4B). There was a signiWcant inhibition
of the absorbance loss at 380 nm, and the increase of
absorbance between 450 and 480 nm was inhibited. These
data suggest that arrestin stabilizes rhodopsin in a Meta
II-like state and inhibits retinal release and Meta III
formation.The presence of SchiV-base was assessed by acidiWcation of
the samples after photodecay in the experiments described
above (Fig. 4C). Protonated SchiV-bases absorb at 440nm
and are indicative of retinal attached to opsin (as in the case
of Meta II and Meta III) or linked to phospholipid. In the
absence of arrestin, addition of acid to photo-decayed Rho*-P
resulted in a broadened absorbance (max »416nm) that is
typical for retinal adducts with asolectin phospholipids. In the
presence of arrestin, acidiWcation resulted in a 440nm absor-
bance peak that veriWes the NaBH4-reduction data (Fig. 3):
arrestin traps retinal in a SchiV-base linked form.
3.5. Arrestin converts thermal Meta III to spectral Meta II
The above results clearly show that arrestin can prevent
accumulation of Meta III. We next tested whether Meta III
could interact with arrestin directly, as it can withFig. 4. Arrestin stabilizes Meta II and converts Meta III to spectral Meta II. (A) The absorbance of Rho-P in DM/asolectin mixed micelles was observed in
the dark (thick solid spectrum) and after photoactivation (dashed spectrum). Spectra were subsequently recorded every 3 min (thin solid spectra) for
120 min (the last spectrum is thick). The arrows indicate the loss of absorbance at 380 nm and the increase in absorbance at 440–480 nm over time. (B) The
same experiment as described in (A) in the presence of a twofold excess of arrestin. (C) The amount of retinal SchiV-base remaining at the end of the exper-
iments described in (A) and (B) was assessed by adding H2SO4 (protonated SchiV-bases absorb at 440 nm). (D) DiVerence spectra representing the conver-
sion of »470 nm absorbance to »380 nm absorbance at 1, 2.5, 4, 8.5, 17.5, 50 and 90 min after the addition of arrestin (the Wrst and last spectra are labeled).
Arrestin was added to photo-decayed Rho*-P 27 min after photoactivation, and absorbance spectra were subsequently recorded. DiVerence spectra were
calculated by subtracting a base line spectrum derived from a control experiment in which an equal volume of buVer was added at t D 27 min after photo-
activation. (Inset) The converted species (380 nm) is most likely Meta II, since acidiWcation at 90 min after the addition of arrestin yields more of the
440 nm absorbance (indicative of retinal SchiV-base) than the control where no arrestin was added. (E) Arrestin speeds the depletion of the 475 nm species
over time. The arrow marks the time at which buVer (closed circles) or arrestin (open circles) was added. The data points represent the average from three
independent experiments, and the error bars represent the standard error. In each experiment, 1 M Rho-P in 20 mM Hepes, 150 mM NaCl, pH 7.4, 0.02%
DM, 0.02% asolectin was used (20 °C), and in part (D) arrestin was added to a Wnal concentration of 1.5 M. The data shown in parts (D and E) was
reported previously (Sommer et al., 2006).
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sure this interaction in detergent allows clear observation of
rhodopsin’s spectral intermediates free of scattering arti-
facts. With membranes, these experiments are complicated
by the fact that arrestin binding to vesicles results in a
signiWcant increase in scattering (Schleicher, Kühn, & Hof-
mann, 1989).
Adding arrestin to Rho*-P 27 min after photoactivation
(20 °C) resulted in a clear decrease at 470 nm (Meta III) and
increase at 380 nm (Fig. 4D). This 380 nm species is charac-
terized by an intact SchiV-base, and is thus likely Meta II
(Fig. 4D, inset). Although some decay of Meta III in the
absence of arrestin was observed, arrestin clearly speeds its
depletion (Fig. 4E). Furthermore, in the absence of arrestin,
no signiWcant increase in absorbance at 380 nm was
observed as Meta III decays, because Meta II was not stabi-
lized (data not shown). Note that in the presence of arres-
tin, the absorbance at 475 nm did not return to the starting
state level, probably because retinal-phospholipid adducts
absorbing in that region were formed before the addition of
arrestin.
3.6. Arrestin interacts with the blue-light photoproduct P470 
but not with photoproduct P500
We next explored arrestin’s interaction with the photo-
products that result from blue-light irradiation of Meta II,
which include species that absorb at »470 and »500 nm
(called P470 and P500, respectively) (Arnis & Hofmann,
1995; Ritter et al., 2004). Although P470 has been shown to
be identical to Meta III (Ritter et al., 2004), the identity of
P500 remains unresolved. Long-believed to be photo-regen-
erated rhodopsin (Arnis & Hofmann, 1995), P500 may in
fact bind all-trans retinal (Bartl et al., 2001). In addition, the
relative proportions of P470 and P500 that form after irra-
diation of Meta II depend on the pH used and may diVer
between detergent- and membrane-bound rhodopsin
(Arnis & Hofmann, 1995; Bartl et al., 2001; Ritter et al.,
2004). It is important to note that in the preliminary experi-
ments described below, we observed species that absorb at
»470 and »500 nm, but we have not formally shown that
these are the same P470 and P500 described above. In addi-
tion, we cannot rule out the possibility that P500 in our
experiments is photo-regenerated dark-state rhodopsin.
The properties of blue-light photoproducts in mixed
micelles are illustrated in Fig. 5A and B. When Meta II
(Fig. 5A, curve ii) is illuminated with blue light (<420 nm),
two absorbance peaks were formed (Fig. 5A, curve iii):
unconverted Meta II (max » 380 nm) and the “P-products”
(max » 480 nm). When hydroxylamine was added to these
photoproducts (Fig. 5B, curve iv), absorbance peaks
3 Previously, it was shown that arrestin can convert 470 nm-absorbing
“pseudo-photoproducts” of rhodopsin, which consist of nonspeciWc com-
plexes of membrane-bound phosphorylated opsin and all-trans retinal,
into species absorbing at 380 nm (Hofmann, Pulvermüller, Buczylko, Van
Hooser, & Palczewski, 1992).corresponding to retinaloxime (max » 365 nm) and P500
(max » 500 nm) were observed. Thus, while P470 is sensitive
to hydroxylamine, P500 is thermally stable and resistant to
hydroxylamine. When P500 was illuminated with green
light in the presence of hydroxylamine, retinaloxime
resulted (Fig. 5B, curve v), suggesting that green light con-
verts P500 to a form that is hydroxylamine sensitive, like
Meta II.
The population of “P-products” formed from the blue-
light irradiation of Meta II showed a gradual loss of 470 nm
absorbance and gain of 380 nm absorbance over time
(Fig. 5C). We assume this is due to thermal decay of P470
to Meta II and/or opsin and free retinal. Since P470 is
equivalent to Meta III (Ritter et al., 2004), we were curious
if arrestin would also interact with P470. Thus, we added
arrestin to a sample of blue-light irradiated Meta II and
found that arrestin speeds the conversion of the »470 nm
species to a Meta II-like species (max » 380 nm) (Fig. 5D).
Furthermore, the relative intensity of the 380 nm peak two
hours after illumination was much greater in the presence
of arrestin. Since Meta II is more absorptive than free reti-
nal, this result suggests that arrestin can interact with P470
and convert it to Meta II, which it stabilizes. In the absence
of arrestin, P470 appears to decay ultimately to opsin and
free retinal.
Interestingly, the rates at which arrestin converts ther-
mal Meta III (Fig. 4E, t1/2 » 10 min) and P470 (Fig. 5D, t1/
2 < 1.5 min) are signiWcantly diVerent, even though similar
amounts of arrestin were used in these experiments (1.5 and
2M, respectively). We are unsure of the cause of this
apparent discrepancy, but it is worth noting that the rho-
dopsin photoproduct population diVered in these experi-
ments. When arrestin was added to photo-decayed Rho*-P
(Fig. 4E), a signiWcant amount of Meta II was present
(»25% of original population), which would have com-
peted for arrestin binding to Meta III. This complicated sit-
uation may explain why the loss of Meta III seen in Fig. 4E
is not described by a simple single-exponential rate (data
not shown). In contrast, the blue light irradiation used in
Fig. 5D resulted in a greatly depleted population of Meta
II, which would have made much more arrestin available
for interaction with P470.
Our data also suggest that arrestin does not interact with
P500, since we Wnd that a hydroxylamine-insensitive peak
(max » 500 nm) remained, even after arrestin was added to
blue-light irradiated Meta II (data not shown).4 We
explored this possibility further by monitoring arrestin
I72B binding after blue-light illumination of Meta II
(Fig. 5E). Note that blue-light irradiation of arrestin-bound
Meta II caused a dramatic drop in the Xuorescence of
4 Note that blue-light illuminated arrestin-bound Meta II produced a
similar distribution of absorbing species as in the absence of arrestin, sug-
gesting that arrestin cannot inhibit the conversion of Meta II to the P-
products (data not shown). In this regard, arrestin may be diVerent than
transducin, which can inhibit the formation of P500 (Arnis & Hofmann,
1995; Bartl et al., 2001).
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fraction of arrestin. We could restore arrestin binding with
subsequent green-light illumination (note the increase in
Xuorescence), and hydroxylamine-catalyzed decay of Meta
II returned the Xuorescence to the dark-state intensity.
Biochemical “pull-down” analysis using membrane-
bound Rho*-P conWrmed these results (Fig. 5F). Interest-
ingly, the Xuorescence proWle in Fig. 5F closely mirrors that
in Fig. 5E. Together, these results suggest arrestin cannot
bind P500 since blue-light irradiation of arrestin-bound
Meta II causes dissociation of arrestin. However, becausearrestin can bind P470, some arrestin remains bound after
blue-light irradiation. Finally, green light can convert P500
to a form which arrestin can bind.
4. Discussion
4.1. Overview of paper
We investigated arrestin binding to Rho*-P in mixed
detergent (DM)/phospholipid micelles to assess how arres-
tin can regulate rhodopsin photochemistry, in a systemFig. 5. Arrestin interacts with the blue-light photoproduct P470 but not P500. (A) The absorbance spectra of Rho-P were recorded (i) in the dark state, (ii)
after illumination with green light (>495 nm, 20 s), and (iii) after subsequent illumination with blue light (<420 nm, 20 s), which results in a mixtures of the
products P470 (Meta III) and P500. (B) The same sample as described in (A), (iv) after the addition of 10 mM hydroxylamine, and (v) after subsequent
illumination with green light (20 s). (C and D) Rho-P was illuminated with green light followed by blue light, as described in (A), and spectra were subse-
quently recorded at 1.5, 3, 4.5, 7.5, and 10.5 min after the addition of 2 M arrestin (D) or and equal volume of buVer (C). DiVerence spectra were calcu-
lated by subtracting the Wrst spectrum after blue-light irradiation from all subsequent spectra after the addition of arrestin or buVer. In each experiment,
1 M Rho-P in 20 mM Hepes, 150 mM NaCl, pH 7.4, 0.02% DM, 0.02% asolectin was used (20 °C). (E) Fluorescence of arrestin I72B (1 M) in the pres-
ence of a twofold excess of Rho-P (0.02% DM, 0.02% asolectin). The sample was illuminated at the indicated times with green or blue light (20 s), and
15 min after the initial illumination, 10 mM hydroxylamine was added. The sample was excited at 380 nm (20 °C). (F) The ability of ROS-P to “pull-down”
arrestin in the dark (lane 1), after green-light illumination (lane 2), after subsequent blue-light illumination (lane 3), after subsequent green-light illumina-
tion (lane 4), and after the addition of 10 mM hydroxylamine (lane 5). The upper panel shows the Xuorescence of the pulled-down arrestin resolved by
SDS–PAGE, and in the lower panel, the Xuorescence of the bands is plotted as a percent of the total arrestin present.
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brane-bound rhodopsin.
Our Wndings are summarized in Fig. 6. BrieXy, we Wnd
that arrestin can stabilize »half the population of retinal in
a SchiV-base linked form with a Meta II-like absorbance
(Figs. 2–4). In this stabilized form, retinal is likely attached
to Lys296, although we cannot exclude the possibility that
retinal may have migrated to another nearby site, perhaps
near Helix VIII (Schädel et al., 2003).
Furthermore, we Wnd that arrestin clearly inhibits Meta
III formation (Fig. 4B). Arrestin is known to favor Meta II at
the expense of Meta I (Schleicher et al., 1989), and since
Meta III evolves from Meta I (Vogel et al., 2004b), these facts
may explain why we see Meta III inhibition in the presence
of arrestin. However, we also Wnd that arrestin can interact
with thermal and blue-light-generated Meta III and convert
it to a species with Meta II-like characteristics (Figs. 4 and5D). The fast conversion of Meta III to Meta II may also
explain the ability of arrestin to inhibit Meta III formation.
Finally, we Wnd that arrestin does not interact with the
blue-light photoproduct P500, although green light can
convert P500 to a form to which arrestin can bind (Fig. 5).
To the best of our knowledge, these results provide the Wrst
insights into the eVect of blue-light on arrestin–rhodopsin
interactions and suggest further investigations are
warranted.
4.2. Caveats for this study
There are several caveats that must accompany the
results reported here. Although the functional soluble sys-
tem described here enables new insight into how arrestin
regulates rhodopsin photochemistry, mixed detergent/lipid
micelles obviously diVer from the native ROS membrane inFig. 6. A cartoon proposing how arrestin can interact with the major photoproducts of phosphorylated rhodopsin. Dark state rhodopsin (Rho) is con-
verted by green light (>495 nm) to Meta I (MI), which is in equilibrium with Meta II (MII). The Meta I/Meta III transition is reversible (Chabre & Breton,
1979; Kolesnikov et al., 2003) and is thought to involve an isomerization of the retinal SchiV-base (Vogel et al., 2003; Vogel et al., 2004b). Meta II decays
ultimately to opsin and all-trans retinal (atR), and Meta III slowly decays to opsin and atR as well (Zimmermann et al., 2004), although it is not known if
this happens directly or through additional intermediates. Blue-light irradiation (<420 nm) of Meta II leads to two photoproducts, P470 (Meta III) and
P500 (Arnis & Hofmann, 1995). Green light can convert P500 back to Meta II (Bartl et al., 2001). The conformation of the chromophore and the proton-
ation state of the SchiV-base (blue proton) is illustrated for each photoproduct, including the isomerization around the SchiV base that occurs during Meta
III formation (Vogel et al., 2003, 2004a, 2004b; Zimmermann et al., 2004). Although it has been shown that P500 most likely binds an all-trans retinal
(Bartl et al., 2001), the exact nature of this photoproduct has not been determined. The selectivity of arrestin for the photoproducts is also illustrated: arr-
estin does not bind dark state Rho-P, P500, or opsin. Arrestin stabilizes Meta II at the expense of Meta I, yielding “extra Meta II” (Schleicher et al., 1989),
and we have shown that arrestin will interact with Meta III/P470 and convert it to Meta II. Arrestin-bound Meta II is stabilized, and its decay to opsin and
free retinal is inhibited. In the Wgure, the Wlled and empty arrows represent conversions that occur in the absence and presence of arrestin, respectively, and
the T-like symbols indicate reactions or interactions which are blocked or inhibited. Note that the protein models are not to scale, and possible binding
stoichiometries (does arrestin bind a dimer of rhodopsin?) are not considered. (For interpretation of the references to colors in this Wgure legend, the
reader is referred to the web version of this paper.)
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known to favor Meta II, perhaps by lowering the activation
energy for the Meta I ! Meta II transition (König, Welte,
& Hofmann, 1989; Litman, Kalisky, & Ottolenghi, 1981).
This may be why we do not observe the signiWcant levels of
Meta III observed in membranes (up to 40%) (Heck et al.,
2003a). Furthermore, we have not formally shown that the
Meta III and blue-light photoproducts we observe are the
same as those reported in membranes.5
The presence of detergent may also disrupt possible sec-
ondary retinal-binding pockets and could thus aVect the
hypothesized channeling of retinal through the protein dur-
ing release (Heck, Schädel, Maretzki, & Hofmann, 2003b;
Schädel et al., 2003). The possible linkage between our
results and the prior reports on retinal channeling is espe-
cially intriguing, considering the diVerences in retinal and
arrestin release in micelles versus membranes. In native
ROS membranes, arrestin slows retinal release, and arrestin
and retinal release occur at the same time (Hofmann et al.,
1992; Sommer et al., 2005). In contrast, only »half of reti-
nal is released and arrestin releases only very slowly in
detergent/lipid micelles (Fig. 2 and (Sommer et al., 2006)).
This phenomenon might suggest a coupling of retinal chan-
neling and arrestin release. Interestingly, addition of deter-
gent to rhodopsin-containing membrane extracts from
Drosophila has also been reported to decouple arrestin
release and the rates of regeneration in the invertebrate
visual cycle (Kiselev & Subramaniam, 1996).
Another possible explanation for the “decoupling” of reti-
nal and arrestin release in detergent is related to the phos-
phorylation status of our rhodopsin samples. Although our
phosphorylation procedure yielded an average of »6 phos-
phates per rhodopsin (Sommer et al., 2005), and thus makes a
large population of nonphosphorylated rhodopsin unlikely, we
cannot rule out the possibility that a population of rhodopsin
exists that contains only one or two phosphates. Perhaps arr-
estin requires higher levels of phosphorylation (>2) in order to
form a long-lived complex with rhodopsin in mixed micelles.
We are currently investigating this possibility, by separating
the diVerent species of phosphorylated rhodopsin as described
(Adamus, Arendt, Hargrave, Heyduk, & Palczewski, 1993;
Aton, Litman, & Jackson, 1984).
Finally, the possible dimerization of rhodopsin might
aVect the dynamics of arrestin and retinal release (Liang
et al., 2003; Mansoor et al., 2006). For example, our data is
consistent with a scenario where arrestin(s) binds a dimer of
rhodopsin, and retinal is released from only one dimer part-
ner (Sommer et al., 2006). However, we cannot rule out the
possibility that, in mixed micelles, rhodopsin may dimerize
in a head-to-tail fashion, as observed in the crystal structure
(Palczewski et al., 2000). We cannot predict what eVect this
manner of dimerization might have on arrestin binding.
5 This would require FTIR analysis of the protein as well as isolation
and identiWcation of the conformation of the retinal chromophore, as de-
scribed (Bartl et al., 2001; Heck et al., 2003a; Vogel et al., 2003; Zimmer-
mann et al., 2004).Despite these unknowns, the preliminary results we
present here represent valuable insight into how arrestin
regulates retinal release and photoproduct formation
from rhodopsin. In the following discussion, we speculate
about the possible implications of our results in the visual
photo-cycle.
4.3. Possible mechanisms of arrestin translocation
Recent studies have explored the mechanisms underlying
the massive light-dependent translocation of arrestin, which
appears important for light adaptation in the rod cell (Elias,
Sezate, Cao, & McGinnis, 2004; Nair et al., 2004; Peterson
et al., 2003; Strissel, Sokolov, Trieu, & Arshavsky, 2006). In
the dark-adapted rod cell, arrestin is normally sequestered in
the inner segment, where microtubules might serve as a “sink”
for arrestin binding (Hanson, Francis, Vishnivetskiy, Klug, &
Gurevich, 2006; Nair et al., 2004). Upon exposure to light, arr-
estin translocates from the inner segment to the outer seg-
ment, where it remains until the removal of light (Elias et al.,
2004). This translocation has been proposed to be governed
by mass action, where arrestin’s aYnity for Rho*-P keeps it in
the outer segment (Nair et al., 2005). However, other studies
suggest that more complex mechanisms, including active
transport, might be involved (Mendez, Lem, Simon, & Chen,
2003; Peterson et al., 2005; Strissel et al., 2006; Zhang et al.,
2003). Remarkably, there may be enough arrestin in the rod
to bind the entire pool of rhodopsin in a completely photo-
bleached cell (Strissel et al., 2006). Since little regeneration of
rhodopsin probably takes place under constant illumination
(Palczewski et al., 1999), the persistence of arrestin in the outer
segment suggests that it might be interacting with a long-lived
photoproduct of rhodopsin. This possibility is supported by
the results we present in this paper.
The fact that arrestin only enters the rod outer segment in
bright light, when the rod cell becomes nonfunctional, sug-
gests arrestin may do more than simply act as a classical sig-
nal terminator. It is more likely that p44, the short splice
variant of arrestin, regulates rhodopsin signaling in the dim-
light operational range of the rod cell (Langlois, Chen,
Palczewski, Hurley, & Vuong, 1996). Consistent with this role,
p44 is present in the outer segment even in the dark (Smith
et al., 1994). The diVerence in dark-state localization between
arrestin and p44 might be due to the high aYnity of p44 for
dark phosphorylated rhodopsin and opsin, which may consti-
tute »1% of the rhodopsin in the dark-adapted rod cell
(Binder, O’Connor, Bownds, & Arshavsky, 1996; Pulvermül-
ler et al., 1997; Schröder, Pulvermüller, & Hofmann, 2002).
Although p44 has a similar aYnity for dark Rho-P and Rho¤-
P, experiments using a Xuorescently labeled p44 analogous to
arrestin I72B suggest that p44 binds dark Rho-P diVerently
than Rho*-P (Sommer, Smith, & Farrens, unpublished
results). The localization of p44 to the ROS membrane may
be a key determinate in its ability to quench Rho¤ activity
quickly (illustrated in Fig. 7) (Langlois et al., 1996; Schröder
et al., 2002). Since p44 is expressed at only »10% the levels of
arrestin, there is suYcient p44 to bind the limited number of
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Fig. 7. Model of light-dependent attenuation of Rho* by p44 and arrestin. In the dark-adapted rod disk (upper panel), p44 (light blue) is “tethered” to the
membrane by its interaction with Rho-P (red), which comprises »1% of the dark-state rhodopsin population (Binder et al., 1996). Transducin (Gt, blue,
green, and orange subunits) and rhodopsin kinase (RK, purple) are also localized to the membrane by lipid membrane anchors (for simplicity, the interac-
tions of RK with recoverin and G are ignored in this schematic). Upon exposure to dim light (middle panels), a single rhodopsin molecule (red) is con-
verted to Meta II (yellow). (1) Gt binds Meta II and is activated. (2) Meta II is phosphorylated by RK. (3) p44 binds phosphorylated Meta II and blocks
further Gt activation. It is not known exactly how p44 “hops” from Rho-P to Rho*-P, but rhodopsin dimerization may facilitate this process (Schröder
et al., 2002). Furthermore, the rapid diVusion of rhodopsin monomeric units in the ROS membrane (Cone, 1972; Liebman & Entine, 1974) may allow p44-
bound Rho-P to come into contact with Rho*-P, but this possibility is speculative. Note that diVerent modes of p44 binding to Rho-P and Rho*-P are
illustrated (see text for more details). Upon exposure to bright light (lowest panel), which results in complete rhodopsin bleaching, arrestin (dark blue)
translocation from the inner segment might provide a pool of protein suYcient to bind up every photo-activated receptor (Strissel et al., 2006). In the
Wgure, rhodopsin dimers and a binding stoichiometry of 2 arrestin to 2 Rho*-P are suggested. (For interpretation of the references to colors in this Wgure
legend, the reader is referred to the web version of this paper.)described below, we postulate that an unappreciated role for
full-length arrestin in the rod cell is a regulator of late photo-
products and retinal release, rather than simply a quencher of
Meta II signaling.
4.4. Possible physiological implications of arrestin’s 
interaction with metarhodopsin III
A form of stationary night blindness called Oguchi
disease is a recessive genetic disorder caused by muta-
tions in either rhodopsin kinase or arrestin. Patients with
Oguchi disease require 5–7 h to dark-adapt, which is
much longer than the normal 40 min (Dryja, 2000; Lamb
& Pugh, 2004). This phenomenon suggests that arrestin
activity is necessary for proper dark adaptation, whichthe rod cells and the regeneration of rhodopsin with 11-
cis retinal. In bright light conditions, up to half of the
rhodopsin in the human retina is estimated to be con-
verted to Meta III (Lewis et al., 1997). Lamb and Pugh
have hypothesized that Oguchi disease is caused by a
build-up of Meta III, which decays much slower in the
absence of arrestin and thus prevents regeneration
(Lamb & Pugh, 2004).
Our results support this hypothesis. We Wnd that phos-
phorylated Meta III can be bound by arrestin and stabi-
lized as a Meta II-like species. In contrast to Meta III,
arrestin-bound Meta II may be more accessible to the
regeneration machinery, which begins with the reduction of
all-trans retinal by retinol dehydrogenase (Hofmann et al.,
1992). Furthermore, arrestin may serve to attenuate Meta
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et al., 2004).
4.5. Arrestin may help limit retinal release to prevent retinal 
degeneration
Arrestin knock-out mice, as well as some Oguchi disease
patients, suVer light-dependent retinal degeneration, which
may be due to excessive signaling (Chen, Simon, Matthes,
Yasumura, & LaVail, 1999; Dryja, 2000; Hao et al., 2002).
However, this phenomenon may not always be caused by
excessive signaling, since bright light-induced retinal degen-
eration in arrestin knock-out mice is independent of trans-
ducin (Hao et al., 2002). Furthermore, bright light-induced
retinal degeneration is characterized by an induction of the
transcription factor AP-1, which suggests that oxidative
stress might be the cause (Reme, 2005).
How might bright light trigger this pro-apototic
redox-sensitive transcription factor? In contrast to
other visual processes, the reduction of retinal to retinol
occurs quite slowly (tens of minutes), which might be due
to the low enzymatic activity of retinol dehydrogenase
(Saari, Garwin, Van Hooser, & Palczewski, 1998),
although other mechanisms might also be involved (Chen
et al., 2005). Thus, in bright-light conditions, levels of free
all-trans retinal might become quite high, which can lead
to the formation of di-retinal conjugates with phosphati-
dylethanolamine (A2E). Light-dependent oxidation of
A2E yields dangerous epoxides, which may be a causative
agent in both age-related (AMD) and Stargardt’s macu-
lar degeneration (Radu, Mata, Bagla, & Travis, 2004;
Sparrow et al., 2003; Wenzel, Grimm, Samardzija, &
Reme, 2005). Note that animals lacking arrestin are sus-
ceptible to retinal damage from bright light, supporting
the suggestion that arrestin serves a protective role in the
rod cell. Consistent with this hypothesis, arrestin expres-
sion appears to be up-regulated when animals are
exposed to light (Organisciak et al., 1991), as is our Wnd-
ing that arrestin can limit the release of retinal and trap it
in stabilized Meta II.
A possible contradiction to this hypothesis is presented
in an in vivo study utilizing arrestin knock-out mice (Pal-
czewski et al., 1999). The authors found no signiWcant
diVerence in the retinoid levels in wild-type and arrestin
knock-out mice, suggesting that arrestin does not play a
critical role in regulating all-trans retinal release. However,
these experiments used dark-adapted mice exposed to a
bright Xash of light. Under these conditions, arrestin would
be mostly sequestered in the inner segment of the rod cell at
the time of the Xash, and this might explain why they
observed no major diVerence between wild-type and arres-
tin knock-out mice. Arrestin’s eVect might be more pro-
nounced in mice which are exposed to constant
illumination. Also, note that even a slight increase in the
amount of free retinal caused by a lack of arrestin could,
over time, lead to an increase in the levels of A2E and other
damaging retinal byproducts.It is interesting to note that when wild-type mice were
exposed to constant illumination, levels of all-trans reti-
nal remained elevated (at »20% of total retinoids) while
the levels of down-stream metabolic products (retinol)
plateaued (Palczewski et al., 1999). This result might
imply that arrestin stabilized a population of Meta II in
the mouse retina. This possibility would be similar to the
invertebrate system, where arrestin stabilizes Metarho-
dopsin and inhibits the release of retinal (Kiselev & Subr-
amaniam, 1996, 1997). It is also interesting to consider
that certain rhodopsin mutations, which constitutively
activate the receptor and are implicated in Retinitis Pig-
mentosa, might lead to inappropriately long-lived arres-
tin–rhodopsin complexes and cytotoxic aggregates
(Chuang, Vega, Jun, & Sung, 2004; Li, Franson, Gordon,
Berson, & Dryja, 1995; Rim & Oprian, 1995). Finally, it
has recently been suggested that retinol dehydrogenase
activity may not be the sole factor that contributes to the
relatively slow conversion of all-trans retinal to retinol in
the rod cell (Chen et al., 2005). It is possible that the sta-
bilization of Meta II by arrestin also contributes (Hof-
mann et al., 1992).
4.6. Possible roles of the blue-light photoproducts
In vitro studies suggest that rod cell exposure to full-
spectrum light might generate P500 as well as Meta III
(Arnis & Hofmann, 1995; Bartl et al., 2001). Although Meta
III appears to have some activity, since it is bound by both
transducin and arrestin, P500 seems to be similar to dark-
state rhodopsin in its inactivity. In vivo investigations have
shown that blue-light irradiation can deactivate a bleached
rod cell (Cone, 1967; Grimm, Reme, Rol, & Williams, 2000;
Huddleston & Williams, 1977), presumably by regenerating
rhodopsin or isorhodopsin, which binds 9-cis retinal. Thus,
the blue-light photoproduct absorbing at »500 nm might
represent another storage form of the protein, and as such
it would make sense that it would not interact with arrestin.
Since P500 can undergo light-dependent activation to a
Meta II-like species, this photoproduct might serve to pre-
serve some light-sensitive pigment in the rod cells after
being exposed to high-bleaching conditions. This mecha-
nism would allow the cell to maintain some sensitivity when
transitioning from bright to dim light conditions before
dark adaptation has occurred.
5. Summary
We described the following results for arrestin–rhodopsin
interactions in a detergent-solubilized system: (1) Arrestin
can inhibit some retinal release from rhodopsin. The retinal is
trapped in a SchiV-base linked form, most likely at Lys296,
with an absorbance characteristic of Meta II (380nm). (2)
Arrestin can interact with Meta III, formed either by thermal
decay or blue-light irradiation, and convert it to a Meta II-
like species. (3) Arrestin does not interact with the blue-light
photoproduct P500, but green light can convert P500 to a
4544 M.E. Sommer, D.L. Farrens / Vision Research 46 (2006) 4532–4546form which arrestin can bind. Although these results may be
unique for arrestin–rhodopsin interactions in a detergent-sol-
ubilized system, they do suggest the possibility that another
role for arrestin in the rod cell might be to limit retinal release
and regulate Meta III, which is consistent with recent physio-
logical evidence supporting this hypothesis.
Acknowledgments
This work was supported in part by National Institutes
of Health Grants DA018169 and EY015436 (to D.L.F.), a
National Defense Science and Engineering Graduate Fel-
lowship (to M.E.S.), and an N.L. Tartar Research Fellow-
ship (to M.E.S.).
References
Adamus, G., Arendt, A., Hargrave, P. A., Heyduk, T., & Palczewski, K.
(1993). The kinetics of multiphosphorylation of rhodopsin. Archives of
Biochemistry and Biophysics, 304(2), 443–447.
Arnis, S., & Hofmann, K. P. (1995). Photoregeneration of bovine rhodop-
sin from its signaling state. Biochemistry, 34(29), 9333–9340.
Aton, B. R., Litman, B. J., & Jackson, M. L. (1984). Isolation and identiW-
cation of the phosphorylated species of rhodopsin. Biochemistry, 23(8),
1737–1741.
Bartl, F. J., Ritter, E., & Hofmann, K. P. (2001). Signaling states of rhodop-
sin: absorption of light in active metarhodopsin II generates an all-
trans-retinal bound inactive state. Journal of Biological Chemistry,
276(32), 30161–30166.
Binder, B. M., O’Connor, T. M., Bownds, M. D., & Arshavsky, V. Y.
(1996). Phosphorylation of non-bleached rhodopsin in intact retinas
and living frogs. Journal of Biological Chemistry, 271(33), 19826–19830.
Bownds, D. (1967). Site of attachment of retinal in rhodopsin. Nature,
216(121), 1178–1181.
Bownds, D., & Wald, G. (1965). Reaction of the rhodopsin chromophore
with sodium borohydride. Nature, 205, 254–257.
Burns, M. E., & Baylor, D. A. (2001). Activation, deactivation, and adapta-
tion in vertebrate photoreceptor cells. Annual Review of Neuroscience,
24, 779–805.
Chabre, M., & Breton, J. (1979). The orientation of the chromophore of
vertebrate rhodopsin in the “meta” intermediate states and the
reversibility of the meta II-meta III transition. Vision Research, 19(9),
1005–1018.
Chen, C., Tsina, E., Cornwall, M. C., Crouch, R. K., Vijayaraghavan, S., &
Koutalos, Y. (2005). Reduction of all-trans retinal to all-trans retinol in
the outer segments of frog and mouse rod photoreceptors. Biophysical
Journal, 88(3), 2278–2287.
Chen, J., Simon, M. I., Matthes, M. T., Yasumura, D., & LaVail, M. M.
(1999). Increased susceptibility to light damage in an arrestin knockout
mouse model of Oguchi disease (stationary night blindness). Investiga-
tive Ophthalmology and Vision Science, 40(12), 2978–2982.
Chuang, J. Z., Vega, C., Jun, W., & Sung, C. H. (2004). Structural and func-
tional impairment of endocytic pathways by Retinitis pigmentosa
mutant rhodopsin–arrestin complexes. Journal of Clinical Investiga-
tion, 114(1), 131–140.
Cone, R. A. (1967). Early receptor potential: photoreversible charge dis-
placement in rhodopsin. Science, 155(766), 1128–1131.
Cone, R. A. (1972). Rotational diVusion of rhodopsin in the visual recep-
tor membrane. Nature: New Biology, 236(63), 39–43.
Dryja, T. P. (2000). Molecular genetics of Oguchi disease, fundus albi-
punctatus, and other forms of stationary night blindness: LVII Edward
Jackson Memorial Lecture. American Journal of Ophthalmology,
130(5), 547–563.
Dupuy, C., Auvray, X., & Petipas, C. (1997). Anomeric eVects on the struc-
ture of micelles of alkyl maltosides in water. Langmuir, 13(15), 3965.Elias, R. V., Sezate, S. S., Cao, W., & McGinnis, J. F. (2004). Temporal
kinetics of the light/dark translocation and compartmentation of arres-
tin and alpha-transducin in mouse photoreceptor cells. Molecular
Vision, 10, 672–681.
Farrens, D. L., Altenbach, C., Yang, K., Hubbell, W. L., & Khorana, H. G.
(1996). Requirement of rigid-body motion of transmembrane helices
for light activation of rhodopsin. Science, 274(5288), 768–770.
Farrens, D. L., & Khorana, H. G. (1995). Structure and function in rho-
dopsin. Measurement of the rate of metarhodopsin II decay by
Xuorescence spectroscopy. Journal of Biological Chemistry, 270(10),
5073–5076.
Fishkin, N., Jang, Y. P., Itagaki, Y., Sparrow, J. R., & Nakanishi, K. (2003).
A2-rhodopsin: a new Xuorophore isolated from photoreceptor outer
segments. Organic and Biomolecular Chemistry, 1(7), 1101–1105.
Grimm, C., Reme, C. E., Rol, P. O., & Williams, T. P. (2000). Blue light’s
eVects on rhodopsin: photoreversal of bleaching in living rat eyes.
Investigative Ophthalmology and Vision Science, 41(12), 3984–3990.
Hamm, H. E. (2001). How activated receptors couple to G proteins. Pro-
ceeding of the National Academic Sciences of the United States of Amer-
ica, 98(9), 4819–4821.
Hanson, S. M., Francis, D. J., Vishnivetskiy, S. A., Klug, C. S., & Gurevich,
V. V. (2006). Visual arrestin binding to microtubules involves a distinct
conformational change. The Journal of Biological Chemistry, in press.
Hao, W., Wenzel, A., Obin, M. S., Chen, C. K., Brill, E., Krasnoperova, N.
V., et al. (2002). Evidence for two apoptotic pathways in light-induced
retinal degeneration. Nature Genetics, 32(2), 254–260.
Heck, M., Schädel, S. A., Maretzki, D., Bartl, F. J., Ritter, E., Palczewski,
K., et al. (2003a). Signaling states of rhodopsin. Formation of the stor-
age form, metarhodopsin III, from active metarhodopsin II. Journal of
Biological Chemistry, 278(5), 3162–3169.
Heck, M., Schädel, S. A., Maretzki, D., & Hofmann, K. P. (2003b). Second-
ary binding sites of retinoids in opsin: characterization and role in
regeneration. Vision Research, 43(28), 3003–3010.
Hofmann, K. P., Pulvermüller, A., Buczylko, J., Van Hooser, P., & Pal-
czewski, K. (1992). The role of arrestin and retinoids in the regenera-
tion pathway of rhodopsin. Journal of Biological Chemistry, 267(22),
15701–15706.
Hubbard, R., & Kropf, A. (1958). The action of light of rhodopsin. Pro-
ceeding of the National Academic Sciences of the United States of Amer-
ica, 44(2), 130–139.
Hubbell, W. L., Altenbach, C., Hubbell, C. M., & Khorana, H. G. (2003).
Rhodopsin structure, dynamics, and activation: a perspective from
crystallography, site-directed spin labeling, sulfhydryl reactivity, and
disulWde cross-linking. Advances in Protein Chemisty, 63, 243–290.
Huddleston, S. K., & Williams, T. P. (1977). Physiological activity of iso-
rhodopsin in rat rods. Vision Research, 17(6), 711–714.
Hurley, J. B., Spencer, M., & Niemi, G. A. (1998). Rhodopsin phosphoryla-
tion and its role in photoreceptor function. Vision Research, 38(10),
1341–1352.
Imamoto, Y., Tamura, C., Kamikubo, H., & Kataoka, M. (2003). Concen-
tration-dependent tetramerization of bovine visual arrestin. Biophysi-
cal Journal, 85(2), 1186–1195.
Kiselev, A., & Subramaniam, S. (1996). Modulation of arrestin release in
the light-driven regeneration of Rh1 Drosophila rhodopsin. Biochemis-
try, 35(6), 1848–1855.
Kiselev, A., & Subramaniam, S. (1997). Studies of Rh1 metarhodopsin sta-
bilization in wild-type Drosophila and in mutants lacking one or both
arrestins. Biochemistry, 36(8), 2188–2196.
Kolesnikov, A. V., Golobokova, E. Y., & Govardovskii, V. I. (2003). The
identity of metarhodopsin III. Visual Neuroscience, 20(3), 249–265.
König, B., Welte, W., & Hofmann, K. P. (1989). Photoactivation of rho-
dopsin and interaction with transducin in detergent micelles. EVect of
‘doping’ with steroid molecules. FEBS Letter, 257(1), 163–166.
Kühn, H., Hall, S. W., & Wilden, U. (1984). Light-induced binding of 48-
kDa protein to photoreceptor membranes is highly enhanced by phos-
phorylation of rhodopsin. FEBS Letter, 176(2), 473–478.
Lamb, T. D., & Pugh, E. N., Jr. (2004). Dark adaptation and the retinoid
cycle of vision. Progress in Retinal and Eye Research, 23(3), 307–380.
M.E. Sommer, D.L. Farrens / Vision Research 46 (2006) 4532–4546 4545Langlois, G., Chen, C. K., Palczewski, K., Hurley, J. B., & Vuong, T. M.
(1996). Responses of the phototransduction cascade to dim light. Pro-
ceeding of the National Academic Sciences of the United States of Amer-
ica, 93(10), 4677–4682.
Lewis, J. W., van Kuijk, F. J., Carruthers, J. A., & Kliger, D. S. (1997). Met-
arhodopsin III formation and decay kinetics: comparison of bovine
and human rhodopsin. Vision Research, 37(1), 1–8.
Li, T., Franson, W. K., Gordon, J. W., Berson, E. L., & Dryja, T. P. (1995).
Constitutive activation of phototransduction by K296E opsin is not a
cause of photoreceptor degeneration. Proceeding of the National Aca-
demic Sciences of the United States of America, 92(8), 3551–3555.
Liang, Y., Fotiadis, D., Filipek, S., Saperstein, D. A., Palczewski, K., &
Engel, A. (2003). Organization of the G protein-coupled receptors rho-
dopsin and opsin in native membranes. Journal of Biological Chemis-
try, 278(24), 21655–21662.
Liebman, P. A., & Entine, G. (1974). Lateral diVusion of visual pigment in
photorecptor disk membranes. Science, 185(149), 457–459.
Litman, B. J., Kalisky, O., & Ottolenghi, M. (1981). Rhodopsin-phospholipid
interactions: dependence of rate of the meta I to meta II transition on the
level of associated disk phospholipid. Biochemistry, 20(3), 631–634.
Mansoor, S. E., McHaourab, H. S., & Farrens, D. L. (1999). Determina-
tion of protein secondary structure and solvent accessibility using
site-directed Xuorescence labeling. Studies of T4 lysozyme using the
Xuorescent probe monobromobimane. Biochemistry, 38(49), 16383–
16393.
Mansoor, S. E., Palczewski, K., & Farrens, D. L. (2006). Rhodopsin self-
associates in asolectin liposomes. Proceeding of the National Academic
Sciences of the United States of America, 103(9), 3060–3065.
Mendez, A., Lem, J., Simon, M., & Chen, J. (2003). Light-dependent trans-
location of arrestin in the absence of rhodopsin phosphorylation and
transducin signaling. Journal of Neuroscience, 23(8), 3124–3129.
Nair, K. S., Hanson, S. M., Kennedy, M. J., Hurley, J. B., Gurevich, V. V.,
& Slepak, V. Z. (2004). Direct binding of visual arrestin to microtu-
bules determines the diVerential subcellular localization of its splice
variants in rod photoreceptors. Journal of Biological Chemistry,
279(39), 41240–41248.
Nair, K. S., Hanson, S. M., Mendez, A., Gurevich, E. V., Kennedy, M. J.,
Shestopalov, V. I., et al. (2005). Light-dependent redistribution of arres-
tin in vertebrate rods is an energy-independent process governed by
protein–protein interactions. Neuron, 46(4), 555–567.
Niu, L., Kim, J. M., & Khorana, H. G. (2002). Structure and function in
rhodopsin: asymmetric reconstitution of rhodopsin in liposomes. Pro-
ceeding of the National Academic Sciences of the United States of Amer-
ica, 99(21), 13409–13412.
Organisciak, D. T., Xie, A., Wang, H. M., Jiang, Y. L., Darrow, R. M., &
Donoso, L. A. (1991). Adaptive changes in visual cell transduction
protein levels: eVect of light. Experimental Eye Research, 53(6), 773–
779.
Palczewski, K., Buczylko, J., Ohguro, H., Annan, R. S., Carr, S. A.,
Crabb, J. W., et al. (1994). Characterization of a truncated form of
arrestin isolated from bovine rod outer segments. Protein Science,
3(2), 314–324.
Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H.,
Fox, B. A., et al. (2000). Crystal structure of rhodopsin: a G protein-
coupled receptor. Science, 289(5480), 739–745.
Palczewski, K., Van Hooser, J. P., Garwin, G. G., Chen, J., Liou, G. I., &
Saari, J. C. (1999). Kinetics of visual pigment regeneration in excised
mouse eyes and in mice with a targeted disruption of the gene encoding
interphotoreceptor retinoid-binding protein or arrestin. Biochemistry,
38(37), 12012–12019.
Parkes, J. H., Gibson, S. K., & Liebman, P. A. (1999). Temperature and pH
dependence of the metarhodopsin I–metarhodopsin II equilibrium and
the binding of metarhodopsin II to G protein in rod disk membranes.
Biochemistry, 38(26), 8598.
Peterson, J. J., Orisme, W., Fellows, J., McDowell, J. H., Shelamer, C. L.,
Dugger, D. R., et al. (2005). A role for cytoskeletal elements in the light-
driven translocation of proteins in rod photoreceptors. Investigative
Ophthalmology and Vision Science, 46(11), 3988–3998.Peterson, J. J., Tam, B. M., Moritz, O. L., Shelamer, C. L., Dugger, D. R.,
McDowell, J. H., et al. (2003). Arrestin migrates in photoreceptors in
response to light: a study of arrestin localization using an arrestin-GFP
fusion protein in transgenic frogs. Experimental Eye Research, 76(5),
553–563.
Plack, P. A., & Pritchard, D. J. (1969). SchiV bases formed from retinal and
phosphatidylethanolamine, phosphatidylserine, ethanolamine or ser-
ine. Biochemical Journal, 115(5), 927–934.
Pulvermüller, A., Maretzki, D., Rudnicka-Nawrot, M., Smith, W. C., Pal-
czewski, K., & Hofmann, K. P. (1997). Functional diVerences in the
interaction of arrestin and its splice variant, p44, with rhodopsin. Bio-
chemistry, 36(30), 9253–9260.
Radu, R. A., Mata, N. L., Bagla, A., & Travis, G. H. (2004). Light exposure
stimulates formation of A2E oxiranes in a mouse model of Stargardt’s
macular degeneration. Proceeding of the National Academic Sciences of
the United States of America, 101(16), 5928–5933.
Reme, C. E. (2005). The dark side of light: rhodopsin and the silent death
of vision the proctor lecture. Investigative Ophthalmology and Vision
Science, 46(8), 2672–2682.
Ridge, K. D., Abdulaev, N. G., Sousa, M., & Palczewski, K. (2003). Photo-
transduction: crystal clear. Trends in Biochemical Sciences, 28(9), 479–487.
Rim, J., & Oprian, D. D. (1995). Constitutive activation of opsin: interac-
tion of mutants with rhodopsin kinase and arrestin. Biochemistry,
34(37), 11938–11945.
Ritter, E., Zimmermann, K., Heck, M., Hofmann, K. P., & Bartl, F. J.
(2004). Transition of rhodopsin into the active metarhodopsin II state
opens a new light-induced pathway linked to SchiV base isomerization.
Journal of Biological Chemistry, 279(46), 48102–48111.
Saari, J. C., Garwin, G. G., Van Hooser, J. P., & Palczewski, K. (1998).
Reduction of all-trans-retinal limits regeneration of visual pigment in
mice. Vision Research, 38(10), 1325–1333.
Schädel, S. A., Heck, M., Maretzki, D., Filipek, S., Teller, D. C., Palczewski,
K., et al. (2003). Ligand channeling within a G-protein-coupled recep-
tor. The entry and exit of retinals in native opsin. Journal of Biological
Chemistry, 278(27), 24896–24903.
Schertler, G. F. (2005). Structure of rhodopsin and the metarhodopsin I
photointermediate. Current Opinion in Structural Biology, 15(4), 408–415.
Schleicher, A., Kühn, H., & Hofmann, K. P. (1989). Kinetics, binding con-
stant, and activation energy of the 48-kDa protein–rhodopsin complex
by extra-metarhodopsin II. Biochemistry, 28(4), 1770–1775.
Schröder, K., Pulvermüller, A., & Hofmann, K. P. (2002). Arrestin and its
splice variant Arr1-370A (p44). Mechanism and biological role of their
interaction with rhodopsin. Journal of Biological Chemistry, 277(46),
43987–43996.
Smith, W. C., Milam, A. H., Dugger, D., Arendt, A., Hargrave, P. A., & Pal-
czewski, K. (1994). A splice variant of arrestin. Molecular cloning and
localization in bovine retina. Journal of Biological Chemistry, 269(22),
15407–15410.
Sommer, M. E., Smith, W. C., & Farrens, D. L. (2005). Dynamics of arres-
tin–rhodopsin interactions: arrestin and retinal release are directly
linked events. Journal of Biological Chemistry, 280(8), 6861–6871.
Sommer, M. E., Smith, W. C., & Farrens, D. L. (2006). Dynamics of arres-
tin–rhodopsin interactions: acidic phospholipids enable binding of arr-
estin to puriWed rhodopsin in detergent. Journal of Biological
Chemistry, 281(14), 9407–9417.
Sparrow, J. R., Fishkin, N., Zhou, J., Cai, B., Jang, Y. P., Krane, S., et al.
(2003). A2E, a byproduct of the visual cycle. Vision Research, 43(28),
2983–2990.
Strissel, K. J., Sokolov, M., Trieu, L. H., & Arshavsky, V. Y. (2006). Arres-
tin translocation is induced at a critical threshold of visual signaling
and is superstoichiometric to bleached rhodopsin. Journal of Neurosci-
ence, 26(4), 1146–1153.
Vogel, R., Ludeke, S., Radu, I., Siebert, F., & Sheves, M. (2004a). Photore-
actions of metarhodopsin III. Biochemistry, 43(31), 10255–10264.
Vogel, R., Siebert, F., Mathias, G., Tavan, P., Fan, G., & Sheves, M. (2003).
Deactivation of rhodopsin in the transition from the signaling state
meta II to meta III involves a thermal isomerization of the retinal chro-
mophore C[double bond]D. Biochemistry, 42(33), 9863–9874.
4546 M.E. Sommer, D.L. Farrens / Vision Research 46 (2006) 4532–4546Vogel, R., Siebert, F., Zhang, X. Y., Fan, G., & Sheves, M. (2004b). Forma-
tion of Meta III during the decay of activated rhodopsin proceeds via
Meta I and not via Meta II. Biochemistry, 43(29), 9457–9466.
Wald, G. (1968). Molecular basis of visual excitation. Science, 162(850),
230–239.
Wenzel, A., Grimm, C., Samardzija, M., & Reme, C. E. (2005). Molecular
mechanisms of light-induced photoreceptor apoptosis and neuropro-
tection for retinal degeneration. Progress in Retinal and Eye Research,
24(2), 275–306.
Wilden, U., Hall, S. W., & Kühn, H. (1986). Phosphodiesterase activation
by photoexcited rhodopsin is quenched when rhodopsin is phosphory-lated and binds the intrinsic 48-kDa protein of rod outer segments.
Proceeding of the National Academic Sciences of the United States of
America, 83(5), 1174–1178.
Zhang, H., Huang, W., Zhu, X., Craft, C. M., Baehr, W., & Chen, C. K.
(2003). Light-dependent redistribution of visual arrestins and trans-
ducin subunits in mice with defective phototransduction. Molecular
Vision, 9, 231–237.
Zimmermann, K., Ritter, E., Bartl, F. J., Hofmann, K. P., & Heck, M.
(2004). Interaction with transducin depletes metarhodopsin III: a regu-
lated retinal storage in visual signal transduction? Journal of Biological
Chemistry, 279(46), 48112–48119.
